![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project
The latest European Guidelines of Arterial Hypertension have officially introduced uric acid evaluation among the cardiovascular risk factors that should be evaluated in order to stratify patient’s risk. In fa...
-
Article
Open AccessP6.16 Left Ventricular Geometry and Carotid Vascular Damage in Patients Undergoing Coronary Angiography
Vascular structural(intima-media thickness, IMT) and functional(carotid stiffness, cPWV)alterations are related to different pattern of left ventricular (LV) geometry in general populations and in hypertensive...
-
Article
Open AccessP5.24: Pulmonary Arterial Hypertension and Arterial Stiffness
Endothelium plays an important role in the development and progression of Pulmonary Arterial Hypertension (PAH), independently of its aetiology. Little is known on derived central blood pressure (CBP) and arte...
-
Article
5.3 Left Ventricular Mass Independently Contributes to Long-Term Risk of Cardiovascular Morbidity and Mortality in a General Population: Data From the PAMELA Study
-
Article
2.4 White Coat and Masked Hypertension Increase the Risk of New Onset Sustained Hypertension in the General Population
-
Article
2.3 New-Onset Diabetes Mellitus and Impaired Fasting Glucose in White Coat, Masked And Sustained Hypertension: the PAMELA Study
-
Article
9.9 Role of the Different Components of Metabolic Syndrome in the Pathogenesis of Adrenergic Overdrive
-
Article
2.3 Prevalence of the Metabolic Syndrome in HIV Patients